SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001032210-02-000525
Filing Date
2002-03-29
Accepted
2002-03-29 00:00:00
Documents
5
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K FOR PERIOD ENDED 12/31/2001 d10k.txt 10-K 257868
3 FORM OF INDEMNIFICATION AGREEMENT dex1019.txt EX-10.19 40752
4 ISDA MASTER AGREEMENT DATED AS OF JANUARY 25, 2002 dex1020.txt EX-10.20 104912
5 SUBSIDIARIES OF THE REGISTRANT dex211.txt EX-21.1 337
6 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.txt EX-23.1 850
  Complete submission text file 0001032210-02-000525.txt   406647
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12465 | Film No.: 02594768
SIC: 2834 Pharmaceutical Preparations